Home/Australian Tariffs/From Israel/Pharmaceutical products

Importing Pharmaceutical products from Israel into Australia (2026)

No Australia-Israel FTA exists, so MFN tariff rates apply to all Chapter 30 pharmaceutical imports from Israel; the single most critical obligation is confirming each product holds a current ARTG registration before shipment, as ABF will hold unregistered therapeutic goods at the border regardless of origin.

No FTA — MFN rates applyHS Chapter 30

Compliance requirements

  • Verify each Israeli pharmaceutical line item has a valid ARTG entry number before booking freight.
  • Ensure your TGA Import Licence explicitly covers the specific Israeli pharmaceutical goods being imported.
  • If shipment includes narcotics or psychotropics, lodge ODC permit application at least 15 business days before departure.
  • All therapeutic goods for human use must be listed or registered on the Australian Register of Therapeutic Goods (ARTG) before importation — ABF will hold shipments if the ARTG entry cannot be confirmed at the border
  • The importer must hold a current TGA Manufacturing or Import Licence (issued under the Therapeutic Goods Act 1989) — this licence must match the specific goods being imported, and spot audits do occur
  • Narcotic, psychotropic, and certain precursor substances require a permit from the Office of Drug Control (ODC) under the Narcotic Drugs Act before each shipment; permits are shipment-specific so plan lead times of 10–15 business days
  • Biological medicines, vaccines, and any product of animal origin require DAFF biosecurity assessment and may need a Biosecurity Import Permit — cold-chain integrity documentation is also scrutinised at the border for temperature-sensitive biologics
  • Goods exempt from ARTG registration (e.g. certain compounded medicines or personal use exemptions) still require a formal TGA exemption reference to be cited on the import declaration to avoid ABF detention
  • No FTA exists between Australia and Israel so MFN (general) tariff rates apply to all goods; a commercial invoice and packing list confirming Israeli origin are required for entry documentation
  • Pharmaceutical and chemical products (Chapters 29, 30, 38) may require TGA registration or AICIS (formerly NICNAS) assessment prior to importation, and detailed safety data sheets must accompany shipments
  • Electrical and electronic goods (Chapter 85) must comply with ACMA regulatory arrangements including RCM marking under the Electrical Equipment Safety System (EESS) before being supplied in the Australian market
  • Biosecurity Act 2015 requirements apply to any organic material, food products, cosmetics or goods with plant or animal inputs; an Import Permit may be required and ABF biosecurity inspections are likely at the border

Key documents required

  • commercial invoice citing ARTG registration or listing number for each product line
  • TGA Import Licence or Manufacturing Licence copy (held by the importer of record)
  • Office of Drug Control (ODC) import permit for controlled substances (Schedule 8 or precursor chemicals)
  • Certificate of Analysis (CoA) and Manufacturer's Certificate of GMP Compliance or equivalent TGA-accepted GMP clearance
  • DAFF Biosecurity Import Permit and cold-chain temperature records for biologics, vaccines, or animal-derived products

Import tip

Lodge your ODC controlled substance import permit application at least three weeks before the vessel or aircraft departs origin — ODC permits cannot be expedited after shipment, and a single missing permit number on the import declaration will result in ABF referral and potential destruction of the consignment.

Calculate the total landed cost for Chapter 30 goods from Israel — duty, GST, IPC, and biosecurity included.

Other product categories imported from Israel